These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 16362828)
1. Diagnostic investigation and multidisciplinary management in motor neuron disease. Rocha JA; Reis C; Simões F; Fonseca J; Mendes Ribeiro J J Neurol; 2005 Dec; 252(12):1435-47. PubMed ID: 16362828 [TBL] [Abstract][Full Text] [Related]
2. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653 [TBL] [Abstract][Full Text] [Related]
3. Evaluation and rehabilitation of patients with adult motor neuron disease. Francis K; Bach JR; DeLisa JA Arch Phys Med Rehabil; 1999 Aug; 80(8):951-63. PubMed ID: 10453774 [TBL] [Abstract][Full Text] [Related]
4. Motor neurone disease - caring for the patient in general practice. Zoing M; Kiernan M Aust Fam Physician; 2011 Dec; 40(12):962-6. PubMed ID: 22146323 [TBL] [Abstract][Full Text] [Related]
5. [Cerebellar symptoms in motor neuron diseases. Special form of amyotrophic lateral sclerosis plus syndrome]. Schimke N; Krampfl K; Petri S; Dengler R; Bufler J Nervenarzt; 2002 Aug; 73(8):751-3. PubMed ID: 12242962 [TBL] [Abstract][Full Text] [Related]
6. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Miller RG; Mitchell JD; Lyon M; Moore DH Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806 [TBL] [Abstract][Full Text] [Related]
7. Optimizing care of patients with ALS. Steps to early detection and improved quality of life. Mackin GA Postgrad Med; 1999 Apr; 105(4):143-6, 151-6. PubMed ID: 10223093 [TBL] [Abstract][Full Text] [Related]
8. Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis. Hodgkinson VL; Lounsberry J; Mirian A; Genge A; Benstead T; Briemberg H; Grant I; Hader W; Johnston WS; Kalra S; Linassi G; Massie R; Melanson M; O'Connell C; Schellenberg K; Shoesmith C; Taylor S; Worley S; Zinman L; Korngut L Can J Neurol Sci; 2018 Nov; 45(6):652-659. PubMed ID: 30430962 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Clinical Management of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. Goutman SA Continuum (Minneap Minn); 2017 Oct; 23(5, Peripheral Nerve and Motor Neuron Disorders):1332-1359. PubMed ID: 28968365 [TBL] [Abstract][Full Text] [Related]
11. [Differential diagnosis and atypical subsets of amyotrophic lateral sclerosis]. Pradat PF; Bruneteau G Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S81-4S90. PubMed ID: 17128093 [TBL] [Abstract][Full Text] [Related]
12. Amyotrophic Lateral Sclerosis: An Update for 2018. Oskarsson B; Gendron TF; Staff NP Mayo Clin Proc; 2018 Nov; 93(11):1617-1628. PubMed ID: 30401437 [TBL] [Abstract][Full Text] [Related]
13. Demographics and clinical characteristics of primary lateral sclerosis: case series and a review of literature. Ramanathan RS; Rana S Neurodegener Dis Manag; 2018 Feb; 8(1):17-23. PubMed ID: 29316850 [TBL] [Abstract][Full Text] [Related]
16. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G; Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545 [TBL] [Abstract][Full Text] [Related]
17. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model. Conde B; Winck JC; Azevedo LF Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082 [TBL] [Abstract][Full Text] [Related]